Personal health is at the heart of everything we do at ANTG. We are motivated by the possibilities and health benefits that medicinal cannabis offers.
We combine a strong research focus with best in class cultivation and extraction systems to produce exclusive, pharmaceutical grade, Australian cannabinoid-based medicines for patients worldwide.
“ANTG are the only GMP, GACP producer of Australian grown, Australian made cannabis flower, certifying that all our products meet the highest pharmaceutical quality standards globally”
MUNESH SUBASH, ANTG GLOBAL QUALITY & REGULATORY AFFAIRS DIRECTOR.
“WE ARE STARTING TO UNLOCK THE IMMENSE THERAPEUTIC POTENTIAL OF A PLANT WHICH HAS AN ARRAY OF BENEFICIAL HEALTH PROPERTIES.”
PROF. JEROME SARRIS, NHMRC CLINICAL RESEARCH FELLOW, NICM HEALTH RESEARCH INSTITUTE, WESTERN SYDNEY UNIVERSITY
ANTG has listed two new THC-dominant medicinal cannabis strains on the Australian Register of Therapeutic Goods (ARTG).
In conjunction with the HMRI and lead biomedical scientist Dr Matt Dun, we’re investigating the anticancer properties of our plant varieties. Dr Matt Dun shares his initial thoughts on the joint research project.
What’s most important in business – purpose or profit? At ANTG we get to achieve both.
We’re pleased to announce we have successfully passed the TGO93 and TGO100 mandatory tests for our first commercial export crop.
We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.
LEARN ABOUT ANTG HERE >
